IRIS
DOTTA, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.525
EU - Europa 10.929
AS - Asia 1.854
AF - Africa 48
OC - Oceania 26
SA - Sud America 26
Continente sconosciuto - Info sul continente non disponibili 12
Totale 28.420
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.491
GB - Regno Unito 3.111
IE - Irlanda 2.038
IT - Italia 1.520
CN - Cina 1.348
UA - Ucraina 1.231
SE - Svezia 974
FR - Francia 574
DE - Germania 511
RU - Federazione Russa 312
FI - Finlandia 310
SG - Singapore 207
ES - Italia 136
VN - Vietnam 99
BE - Belgio 73
IN - India 62
TR - Turchia 42
CI - Costa d'Avorio 38
NL - Olanda 30
CA - Canada 28
AU - Australia 24
KR - Corea 20
CZ - Repubblica Ceca 19
PK - Pakistan 16
BR - Brasile 15
IR - Iran 14
JP - Giappone 13
EU - Europa 12
GR - Grecia 12
HU - Ungheria 12
CH - Svizzera 11
DK - Danimarca 10
HK - Hong Kong 9
PL - Polonia 8
RO - Romania 7
AT - Austria 5
EG - Egitto 5
PE - Perù 5
PT - Portogallo 5
CL - Cile 4
ID - Indonesia 4
IL - Israele 4
DZ - Algeria 3
IM - Isola di Man 3
LT - Lituania 3
LU - Lussemburgo 3
MX - Messico 3
SA - Arabia Saudita 3
CO - Colombia 2
CY - Cipro 2
EE - Estonia 2
KW - Kuwait 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
RS - Serbia 2
TH - Thailandia 2
AM - Armenia 1
BD - Bangladesh 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
HR - Croazia 1
IQ - Iraq 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LV - Lettonia 1
MD - Moldavia 1
MT - Malta 1
NO - Norvegia 1
PA - Panama 1
SI - Slovenia 1
Totale 28.420
Salva come PNG Salva come JPEG
Città #
Southend 2.888
Fairfield 2.662
Dublin 2.021
Houston 1.599
Ashburn 1.316
Chandler 1.256
Woodbridge 1.186
Jacksonville 997
Seattle 986
Wilmington 944
Cambridge 901
Ann Arbor 547
Princeton 455
Siena 422
Nanjing 351
Beijing 288
Boardman 170
Florence 145
New York 144
San Diego 142
San Mateo 132
Nanchang 124
Málaga 123
Singapore 121
Helsinki 119
Dong Ket 99
Moscow 89
Shanghai 73
Shenyang 65
Changsha 58
Rome 58
Milan 57
Hebei 54
Tianjin 53
Dearborn 51
Jiaxing 49
Kunming 46
London 40
Abidjan 38
Atlanta 38
Falls Church 38
Norwalk 37
Brussels 34
Zhengzhou 32
Munich 31
Washington 29
Fremont 28
Leuven 27
Izmir 25
San Francisco 24
Ningbo 23
Hangzhou 21
Jinan 21
Los Angeles 19
Brno 18
Pisa 18
Düsseldorf 17
Guangzhou 16
Phoenix 16
Toronto 16
Venezia 16
Saronno 15
Edinburgh 14
Redwood City 14
Palermo 13
Tappahannock 13
Amsterdam 12
Budapest 12
Dallas 12
Prato 12
Napoli 11
Redmond 11
Chicago 10
Hefei 10
Taizhou 10
Changchun 9
Kraainem 9
Melbourne 9
Bologna 8
Copenhagen 8
Enfield 8
Kilburn 8
Lanzhou 8
Lastra a Signa 8
Livorno 8
Mori 8
Padova 8
Prescot 8
Udine 8
Vaiano 8
Chiswick 7
Karachi 7
Stockholm 7
Bergamo 6
Berlin 6
Cagliari 6
Central 6
Codogno 6
Lahore 6
Venafro 6
Totale 21.768
Salva come PNG Salva come JPEG
Nome #
Markers of beta cell function in type 1 diabetes mellitus 570
null 398
Urban diabetes: The case of the metropolitan area of Rome 388
Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice. The NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetes. 274
G-protein coupled receptors (GPCRs) in the treatment of diabetes: Current view and future perspectives 215
MicroRNA expression in the aqueous humor of patients with diabetic macular edema 204
Lymphocyte-derived exosomal microRNAs promote pancreatic β-cell death and may contribute to type 1 diabetes development. 201
HbA1c Variability As an Independent Correlate of Nephropathy, but Not Retinopathy, in Patients With Type 2 Diabetes: The Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study 200
Circulating microRNAs and diabetes mellitus: a novel tool for disease prediction, diagnosis, and staging? 190
Dapagliflozin modulates glucagon secretion in an SGLT2-independent manner in murine alpha cells 187
Regulatory T-cells from pancreatic lymphnodes of patients with type-1 diabetes express increased levels of microRNA miR-125a-5p that limits CCR2 expression 186
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 185
Circulating microRNA (miRNA) expression profiling in plasma of patients with gestational diabetes mellitus reveals upregulation of miRNA miR-330-3p 184
MicroRNAs as Regulators of Insulin Signaling: Research Updates and Potential Therapeutic Perspectives in Type 2 Diabetes 181
Islet-reactive CD8+T cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors 180
Putative endothelial progenitor cells predict long-term mortality in type-2 diabetes 177
Serum Levels of miR-148a and miR-21-5p Are Increased in Type 1 Diabetic Patients and Correlated with Markers of Bone Strength and Metabolism 177
miR-409-3p is reduced in plasma and islet immune infiltrates of NOD diabetic mice and is differentially expressed in people with type 1 diabetes 176
MicroRNAs: markers of β-cell stress and autoimmunity 176
MicroRNA expression analysis of in vitro dedifferentiated human pancreatic islet cells reveals the activation of the pluripotency-related microRNA cluster miR-302s 174
Circulating MicroRNAs as biomarkers of gestational diabetes mellitus: Updates and perspectives 170
MicroRNAs miR-23a-3p, miR-23b-3p, and miR-149-5p regulate the expression of proapoptotic bh3-only proteins DP5 and PUMA in human pancreatic β-cells 170
From immunohistological to anatomical alterations of human pancreas in type 1 diabetes: New concepts on the stage 170
MicroRNA profiling in sera of patients with type 2 diabetes mellitus reveals an upregulation of miR-31 expression in subjects with microvascular complications 162
Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes 161
Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT Study 161
Unexpected subcellular distribution of a specific isoform of the Coxsackie and adenovirus receptor, CAR-SIV, in human pancreatic beta cells 161
Generalised reduction of putative endothelial progenitors and CXCR4-positive peripheral blood cells in type 2 diabetes. 160
MicroRNA miR-124a, a negative regulator of insulin secretion, is hyperexpressed in human pancreatic islets of type 2 diabetic patients 160
Abnormal neutrophil signature in the blood and pancreas of presymptomatic and symptomatic type 1 diabetes 159
MicroRNA expression profiles of human iPSCs differentiation into insulin-producing cells 159
Telecare Provides comparable efficacy to conventional self-monitored blood glucose in patients with type 2 diabetes titrating one injection of insulin glulisine-the ELEONOR study 159
Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: the RIACE Italian multicentre study 158
Clinical significance of nonalbuminuric renal impairment in type 2 diabetes 153
Chronic kidney disease in type 2 diabetes: Lessons from the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicentre Study 153
Endocrine actions of osteocalcin 150
Conventional and Neo-Antigenic Peptides Presented by β Cells Are Targeted by Circulating Naïve CD8+ T Cells in Type 1 Diabetic and Healthy Donors 150
Circulating miRNA95 and miRNA190 Are Sensitive Markers for the Differential Diagnosis of Thyroid Nodules in a Caucasian Population. 149
Delta-cell specific expression of Hedgehog pathway Ptch1 receptor in murine and human endocrine pancreas 149
Acute on chronic limb ischemia: From surgical embolectomy and thrombolysis to endovascular options 140
Distribution of cardiovascular disease and retinopathy in patients with type 2 diabetes according to different classification systems for chronic kidney disease: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study 139
Incretin Hormones and Beta-cell mass expansion: what we know and what is missing? 139
Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: impact on cardiovascular events. A randomized controlled trial 138
Relative sensitivity of immunohistochemistry, multiple reaction monitoring mass spectrometry, in situ hybridization and PCR to detect Coxsackievirus B1 in A549 cells 138
Coxsackieviruses and Insulitis 138
Combination therapy with metformin plus vildagliptin in type 2 diabetes mellitus 137
Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial 137
Targeting microRNAs as a Therapeutic Strategy to Reduce Oxidative Stress in Diabetes 137
Enteroviral Infections and Development of Type 1 Diabetes: The Brothers Karamazov Within the CVBs. 136
Autoantibodies to the GM2-1 islet ganglioside and to GAD-65 at type 1 diabetes onset 135
Oral delivery of Glutamic Acid Decarboxylase (GAD)-65 and IL10 by Lactococcus lactis reverses diabetes in recent-onset NOD mice. 135
The case for virus-induced type 1 diabetes 134
MicroRNA-124a is hyperexpressed in type 2 diabetic human pancreatic islets and negatively regulates insulin secretion 134
Guidelines for the treatment and management of new-onset diabetes after transplantation 133
Viral Infections and diabetes 133
Prognostic bioindicators in severe COVID-19 patients 133
T-cell mediated autoimmunity to the insulinoma-associated protein 2 islet tyrosine phosphatase in type 1 diabetes mellitus. 132
Assay for cytoplasmic islet cell antibodies using two-color immunofluorescence and rat pancreas 132
Suppressor of cytokine signaling gene expression in human pancreatic islets: modulation by cytokines. 131
Prevention and treatment of autoimmune diseases with plant virus nanoparticles 131
Optimizing insulin glargine plus one injection of insulin glulisine in type 2 diabetes in the ELEONOR study: similar effects of telecare and conventional self-monitoring of blood glucose on patient functional health status and treatment satisfaction. 130
Intensive Structured Self-Monitoring of Blood Glucose and Glycemic Control in Noninsulin-Treated Type 2 Diabetes: The PRISMA Randomized Trial 129
Analysis of posttransplant diabetes mellitus prevalence in a population of kidney transplant recipients. 129
Th2 cytokines have a partial, direct protective effect on the function and survival of isolated human islets exposed to combined proinflammatory and Th1 cytokines. 129
Impaired caspase-3 expression by peripheral T cells in chronic autoimmune thyroiditis and in autoimmune polyendocrine syndrome-2. 128
A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets 128
null 128
Fighting diabetic foot ulcers—The diabetologist: A king maker of the fight 128
Upregulation of mitochondrial peripheral benzodiazepine receptor expression by cytokine-induced damage of human pancreatic islets 127
Application of phage display peptide library to autoimmune diabetes: identification of IA-2/ICA512bdc dominant autoantigenic epitopes 127
Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease 127
Treatment escalation options for patients with type 2 diabetes after failure of exenatide twice daily or glimepiride added to metformin: Results from the prospective European Exenatide (EUREXA) study 127
Virus infections: lessons from pancreas histology 127
Molecular dysfunction and phenotypic derangement in diabetic cardiomyopathy 127
MicroRNAs as new tools for exploring type 1 diabetes: relevance for immunomodulation and transplantation therapy 126
Dietary supplementation with high doses of regular vitamin D3 safely reduces Diabetes incidence in nod mice when given early and long-term. 126
Pancreatic Alpha-Cells Contribute Together With Beta-Cells to CXCL10 Expression in Type 1 Diabetes 126
IA-2 combined epitope assay: a new, highly sensitive approach to evaluate IA-2 humoral autoimmunity in type 1 diabetes 125
In type 1 diabetes immunocompetent cells are defective in IL-16 secretion. 122
An overview of pancreatic beta-cell defects in human type 2 diabetes: implications for treatment 122
Reversal of Diabetes in NOD Mice by Clinical-Grade Proinsulin and IL-10-Secreting Lactococcus lactis in Combination With Low-Dose Anti-CD3 Depends on the Induction of Foxp3-Positive T Cells 122
Italian addison network study: update of diagnostic criteria for the etiological classification of primary adrenal insufficiency. 122
Primary ovarian insufficiency due to steroidogenic cell autoimmunity is associated with a preserved pool of functioning follicles. 121
CD4+CD25high regulatory T cells in human autoimmune diabetes 120
Can NK cells be a therapeutic target in human type 1 diabetes? 120
The acquisition of an insulin-secreting phenotype by HGF-treated rat pancreatic ductal cells (ARIP) is associated with the development of susceptibility to cytokine-induced apoptosis. 120
Identification of tyrosine phosphatase 2(256-760) construct as a new, sensitive marker for the detection of islet autoimmunity in type 2 diabetic patients: the non-insulin requiring autoimmune diabetes (NIRAD) study 2. 119
Autoantibody negative new onset type 1 diabetic patients lacking high risk HLA alleles in a caucasian population: are these type 1b diabetes cases? 119
Reduction of Circulating Neutrophils Precedes and Accompanies Type 1 Diabetes 119
Pathological changes in human insulitis 119
Efficacy and tolerability of vildagliptin vs. pioglitazone when added to metformin: a 24-week, randomized, double-blind study 119
Cytotoxic T lymphocyte antigen-4 Ala17 polymorphism is a genetic marker of autoimmune adrenal insufficiency: Italian association study and meta-analysis of European studies. 118
Photodynamic topical antimicrobial therapy for infected foot ulcers in patients with diabetes: a randomized, double-blind, placebo-controlled study-the D.A.N.T.E (Diabetic ulcer Antimicrobial New Topical treatment Evaluation) study 118
Circulating MicroRNAs in elderly type 2 diabetic patients 118
Effects of prolonged exposure to pancreatic glucagon on the function, antigenicity and survival of isolated human islets 118
Autoantigens in thyroid and islet autoimmunity: similarities and differences 118
Celiac disease-associated transglutaminase autoantibody target domains at diagnosis are age and sex dependent 118
Improved insulin secretory function and reduced chemotactic properties after tissue culture of islets from type 1 diabetic patients 117
Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients 117
Highlights from "Italian Standards of care for Diabetes Mellitus 2009-2010" 116
Totale 15.395
Salva come PNG Salva come JPEG
Categoria #
all - tutte 89.388
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.388
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.996 0 0 519 1.203 586 556 609 861 574 533 189 366
2020/20214.776 194 600 160 472 351 478 234 703 530 372 344 338
2021/20223.296 260 556 209 289 117 101 173 105 145 317 320 704
2022/20234.499 282 318 472 645 475 929 66 358 480 166 197 111
2023/20243.148 149 111 246 136 163 849 978 99 25 124 39 229
2024/2025522 133 389 0 0 0 0 0 0 0 0 0 0
Totale 29.039